These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24880663)

  • 61. UVA irradiation induced heme oxygenase-1: a novel phototherapy for morphea.
    Nisar MF; Parsons KS; Bian CX; Zhong JL
    Photochem Photobiol; 2015; 91(1):210-20. PubMed ID: 25207998
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deep morphea after vaccination in two young children.
    Torrelo A; Suárez J; Colmenero I; Azorín D; Perera A; Zambrano A
    Pediatr Dermatol; 2006; 23(5):484-7. PubMed ID: 17014648
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity.
    Al-Nasrawi AN; Abdulkareem AS; Mohammed Ali MN
    Cureus; 2024 May; 16(5):e61105. PubMed ID: 38919251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical characteristics and histopathologic changes of morphea: A single-center, retrospective study of 137 patients.
    Kim J; Chung KB; Lee YI; Kim J; Lee JH
    J Am Acad Dermatol; 2021 Jul; 85(1):105-113. PubMed ID: 33188871
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea.
    O'Brien JC; Rainwater YB; Malviya N; Cyrus N; Auer-Hackenberg L; Hynan LS; Hosler GA; Jacobe HT
    J Invest Dermatol; 2017 Aug; 137(8):1663-1670. PubMed ID: 28450066
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Morphea and Eosinophilic Fasciitis: An Update.
    Mertens JS; Seyger MMB; Thurlings RM; Radstake TRDJ; de Jong EMGJ
    Am J Clin Dermatol; 2017 Aug; 18(4):491-512. PubMed ID: 28303481
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of the Effectiveness and Tolerability of Mycophenolate Mofetil and Mycophenolic Acid for the Treatment of Morphea.
    Arthur M; Fett NM; Latour E; Jacobe H; Kunzler E; Florez-Pollack S; Houser J; Sharma S; Prasad S; Femia A; Stern MJ; Pappas-Taffer LK; Gaffney R; Fernandez AP; Knabel D; Cardones AR; Leung N; Laumann A; Yu JM; Zhao J; Vleugels RA; Tkachenko E; Lo K
    JAMA Dermatol; 2020 May; 156(5):521-528. PubMed ID: 32236497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Isomorphic phenomenon in morphea.
    Tosti A; Manuzzi P; Bardazzi F
    Dermatologica; 1988; 177(3):192. PubMed ID: 3169346
    [No Abstract]   [Full Text] [Related]  

  • 69. Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients.
    Malewska-Woźniak A; Osmola-Mañkowska A; Adamski Z
    Postepy Dermatol Alergol; 2022 Aug; 39(4):757-761. PubMed ID: 36090739
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Beneficial Effects of Near-Infrared Light Photobiomodulation in Linear Morphea: A Case Report.
    Barolet AC; Litvinov IV; Barolet D
    Photobiomodul Photomed Laser Surg; 2020 Nov; 38(11):679-682. PubMed ID: 33103949
    [No Abstract]   [Full Text] [Related]  

  • 71. From Morphea to Dermatofibrosarcoma Protuberans.
    Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
    Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pediatric morphea (localized scleroderma): review of 136 patients.
    Christen-Zaech S; Hakim MD; Afsar FS; Paller AS
    J Am Acad Dermatol; 2008 Sep; 59(3):385-96. PubMed ID: 18571769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Perineural inflammation in morphea (localized scleroderma): systematic characterization of a poorly recognized but potentially useful histopathological feature.
    Dhaliwal CA; MacKenzie AI; Biswas A
    J Cutan Pathol; 2014 Jan; 41(1):28-35. PubMed ID: 24117981
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Frequency of antinuclear antibodies in mestizo Mexican children with morphea.
    Guevara-Gutiérrez E; Yinh-Lao J; García-Gutiérrez P; Tlacuilo-Parra A
    Clin Rheumatol; 2010 Sep; 29(9):1055-9. PubMed ID: 20549277
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Localized Scleroderma Cutaneous Assessment Tool: responsiveness to change in a pediatric clinical population.
    Kelsey CE; Torok KS
    J Am Acad Dermatol; 2013 Aug; 69(2):214-20. PubMed ID: 23562760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antibodies against antigens related to scleroderma in a cohort of patients with morphea.
    Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F
    G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postirradiation morphea of the breast presentation of two cases and review of the literature.
    Schaffer JV; Carroll C; Dvoretsky I; Huether MJ; Girardi M
    Dermatology; 2000; 200(1):67-71. PubMed ID: 10681621
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Localized scleroderma (morphea) in childhood].
    Weibel L
    Hautarzt; 2012 Feb; 63(2):89-96. PubMed ID: 22290277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma.
    Agazzi A; Fadanelli G; Vittadello F; Zulian F; Martini G
    Pediatr Rheumatol Online J; 2018 Jun; 16(1):37. PubMed ID: 29914516
    [TBL] [Abstract][Full Text] [Related]  

  • 80. No evidence for Borrelia burgdorferi infection in lesions of morphea and lichen sclerosus et atrophicus in Spain. A prospective study and literature review.
    Alonso-Llamazares J; Persing DH; Anda P; Gibson LE; Rutledge BJ; Iglesias L
    Acta Derm Venereol; 1997 Jul; 77(4):299-304. PubMed ID: 9228224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.